| |
|
|
|
Arcadia Biosciences Inc.  
|
|
3.84 0.2 (0.05%) |
06-18 16:00 |
|
Open: |
3.64 |
Pre close: |
3.64 |
Target:
|
6.25
|
|
High: |
3.88 |
Low: |
3.55 |
Resistance:
|
5.35
6.47
|
|
Volume: |
180,147 |
Market Cap: |
24M |
Support:
|
3.54
2.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.22
 |
MACD |
MACD(12,26):
|
-0.38 |
|
MA(20): |
4.81 |
Signal(12,26,9): |
-0.27 |
|
MA(100): |
5.70  |
Stochastic Oscillator |
%K(14,3):
|
5.51 |
|
MA(250): |
5.41 |
%D(3): |
12.05 |
|
Average Volume(K) |
3-Month: |
14064
|
52-Week |
High:
|
10.40 |
|
10-Days: |
29430 |
Low: |
2.64 |
|
RSI |
RSI(14):
|
34.70 |
Change(%): |
-54.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.480 |
Return on Equity (ttm) |
-2495.3 |
Shares Out. (M) |
4.78 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-72.8 |
Shares Float (M) |
4.63 |
|
EPS Est. Next Year |
-0.220 |
PEG Ratio |
-0.11 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
-26.2 |
% Held by Institutions |
10.20 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
37.430 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.10 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.98 |
P/S |
57359996.00 |
|
Operating Margin |
-1225.07 |
Levered Free Cash Flow
(M) |
-9.68 |
P/CF |
-1.22 |
|
|
|
|
|
|
